Cite
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
MLA
Rogers, T. R., et al. “Molecular Mechanisms of Acquired Antifungal Drug Resistance in Principal Fungal Pathogens and EUCAST Guidance for Their Laboratory Detection and Clinical Implications.” Journal of Antimicrobial Chemotherapy, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366901706&authtype=sso&custid=ns315887.
APA
Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., & Arendrup, M. C. (2022). Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications. Journal of Antimicrobial Chemotherapy.
Chicago
Rogers, T.R., P.E. Verweij, Mariana Castanheira, E. Dannaoui, P.L. White, and Maiken C. Arendrup. 2022. “Molecular Mechanisms of Acquired Antifungal Drug Resistance in Principal Fungal Pathogens and EUCAST Guidance for Their Laboratory Detection and Clinical Implications.” Journal of Antimicrobial Chemotherapy. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366901706&authtype=sso&custid=ns315887.